Showing results 1 to 4 of 4
Title | Author(s) | Issue Date | |
---|---|---|---|
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma Journal:Therapeutic Advances in Medical Oncology | 2019 | ||
2013 | |||
Regorafenib in Chinese patients with metastatic colorectal cancer: subgroup analysis of the phase 3 CONCUR trial Journal:Journal of Gastroenterology and Hepatology | 2020 | ||
2015 |